Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

What is Mosaicism & Why Should I Care?

Course / What is Mosaicism & Why Should I Care?

Why Mosaicism Matters

Definition

Embryo mosaicism refers to the presence of two or more cell lines with different chromosomal complements within the same embryo.
For example, an embryo may contain both normal (euploid) and abnormal (aneuploid) cells.

Clinical Importance

  • Mosaicism directly affects embryo selection, reporting, and transfer strategy.

  • It may lead to misinterpretation if biopsy samples don’t represent the entire embryo.

  • Mosaic embryos challenge traditional “normal vs abnormal” classification models.

Impact in Surrogacy & IVF

  • In surrogacy, transferring a mosaic embryo raises specific ethical and counseling implications — since the genetic abnormality may or may not manifest in development.

  • Proper understanding allows agencies and clinics to ensure transparent decision-making among all parties.

A Simple Way to Wrap Your Head Around Mosaicism

Conceptual Model

Think of an embryo as a city made of cells.

  • In a euploid city, every “building” (cell) has the correct blueprint.

  • In a mosaic city, some buildings have a missing or extra floor — the plans vary.

When a small portion of cells (e.g., <30%) are abnormal, it’s called low-level mosaicism.
When a larger portion (e.g., 40–80%) are abnormal, it’s high-level mosaicism.

How It Happens

  • Mitotic errors during early cleavage divisions.

  • Environmental stress in culture or random chromosomal segregation events.

  • Unequal distribution of chromosomal material after fertilization.

Key Takeaway

The biopsy may sample only 5–10 cells from the trophectoderm (outer layer). These may not perfectly represent the inner cell mass that forms the fetus.
Hence, mosaic results are a probabilistic estimate, not an absolute diagnosis.

Will Your Doctor Tell You About Mosaicism If You’re Affected?

Clinical Transparency

In modern PGT-A practice, reputable laboratories must report mosaic findings according to recognized standards (e.g., PGDIS 2021 guidelines).

Clinicians should:

  • Review the full laboratory report and mosaic percentage.

  • Document the counseling process with intended parents.

  • Explain clinical implications, residual risks, and available choices.

For Surrogacy Programs

At Surrogacy4All or similar agencies, transparency is essential:

  • Mosaic findings should be disclosed to intended parents and, when appropriate, to the gestational carrier (with consent and within ethical bounds).

  • Embryo disposition and transfer strategy must follow informed consent procedures.

How Often Does Mosaicism Actually Exist

Incidence Data

  • Detected in 15–25% of blastocysts depending on lab technology and criteria.

  • Frequency increases with maternal age and culture duration.

  • False mosaic calls may arise due to technical noise in next-generation sequencing (NGS).

Lab-Dependent Variation

  • Some labs report <10% mosaicism, others >30%, depending on detection thresholds.

  • Validation of each lab’s mosaic classification system is critical before clinical interpretation.

Key Clinical Insight

Not all mosaic embryos are abnormal — many are self-correcting and can lead to healthy births.
Hence, the clinician’s experience and lab communication are key in interpreting results.

Developing a Transfer Hierarchy With Mosaic Embryos

Stepwise Approach

When both euploid and mosaic embryos are available, transfer priority should follow this hierarchy:

  1. Euploid (normal) embryos

  2. Low-level mosaic embryos involving small chromosomes (e.g., chromosomes 21, 22)

  3. Low-level mosaic embryos with whole-chromosome involvement

  4. High-level mosaic embryos (case-by-case consideration)

  5. Complex or segmental mosaics (transfer only after genetic consultation)

Key Considerations

  • Chromosome type: mosaicism involving critical chromosomes (13, 18, 21, X, Y) may carry higher clinical risk.

  • Percentage mosaicism: <30% considered low-level; >50% high-level.

  • Intended parents’ goals: willingness to accept uncertainty.

  • Surrogacy ethics: ensure full disclosure to all parties involved.

Recommended Protocol

  • Multidisciplinary review (fertility specialist + embryologist + genetic counselor).

  • Documented consent outlining potential outcomes.

  • Pre-transfer ultrasound and prenatal follow-up plan in place.

If You’re Thinking About Transferring a Mosaic Embryo

Clinical Decision-Making Framework

  1. Confirm lab methodology — ensure NGS accuracy and thresholds.

  2. Review embryo morphology and developmental grade — higher-quality mosaics have better implantation potential.

  3. Assess type of mosaicism — segmental vs whole-chromosome.

  4. Discuss outcome data — many published studies show live birth rates of 30–60% for low-level mosaics.

  5. Establish informed consent with intended parents.

Surrogacy-Specific Caution

  • The gestational carrier’s role introduces added medical and legal responsibility.

  • Always involve a licensed genetic counselor and legal advisor prior to transfer approval.

Example Protocol

“At Surrogacy4All, mosaic embryo transfers are only considered after independent genetic review, embryology sign-off, and client consent documentation confirming awareness of clinical variability.”

The Need to Consult a Genetic Counselor

Why It’s Crucial

  • Mosaicism sits at the intersection of science, probability, and ethics.

  • Genetic counselors provide nuanced explanations of residual risk, testing limitations, and pregnancy follow-up options.

  • They help intended parents make informed choices based on chromosome type, mosaic level, and personal values.

Topics Covered in Counseling

  • Mosaic classification terminology (low/high, segmental/whole)

  • Expected outcomes from published cohort studies

  • Prenatal diagnostic options (CVS, amniocentesis) after a mosaic transfer

  • Emotional and ethical guidance for decision-making

Best Practice:
Always include a formal genetic counseling step in any case involving mosaic findings — prior to embryo selection or transfer approval.

Pro Tips (Expert Insights)

  • Partner with PGDIS-compliant laboratories that provide quantitative mosaic reporting.

  • Standardize your internal hierarchy policy for mosaic embryo transfer.

  • Maintain a central tracking database of mosaic outcomes for continuous improvement.

  • Prioritize blastocyst-stage biopsies — cleavage-stage biopsies increase mosaic detection errors.

  • Avoid discarding all mosaic embryos automatically — classify carefully.

  • Include genetic counselor involvement in both embryo reporting and consent discussions.

  • Implement clear documentation workflows within surrogacy programs to ensure legal and ethical transparency.

  • When in doubt, seek secondary lab review — mosaic categorization can vary.